SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Medistep Healthcare Ltd (MEDISTEP)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: MEDISTEP Trading | Small Cap | Medistep Healthcare Share Price

BSE Share Price
Not Listed

Medistep Healthcare Ltd (MEDISTEP)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: MEDISTEP Trading | Small Cap | Medistep Healthcare Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹26 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹4.2
TTM Sales
₹70.8 Cr.
Book Value per Share
₹26.6
P/E Ratio
4.29
Lower than its 5-year historical median
Industry PE
38.7
Price to Book (P/B)
0.68
Lower than its 5-year historical median
Price to Sales (P/S)
0.36
Lower than its 5-year historical median
EV/EBITDA
3.02
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
29.06%
Outperforms industry median
Return on Capital Employed (ROCE)
37.86%
Outperforms industry median
Return on Assets (ROA)
21.85%
Operating Profit Margin
11.3%
Net Profit Margin
8.35%
Gross Profit Margin
11.2%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
57.02%
Operating Profit Growth (1 Year)
-
41.67%
Net Profit Growth (1 Year)
-
42.27%
Asset Quality
Promoter Holding
68.96%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹24 Cr.
Equity
₹14.2 Cr.
Face Value
₹10
All Time Low / High
- / -

Medistep Healthcare stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Medistep Healthcare Ltd a good quality company?
Medistep Healthcare Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Medistep Healthcare Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Medistep Healthcare Ltd vs industry peers?
Medistep Healthcare Ltd revenue CAGR is %, compared to the industry median CAGR of 6.79%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Medistep Healthcare Ltd?
Promoters hold 68.96% of the Medistep Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Medistep Healthcare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Medistep Healthcare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'24Mar'25TTM
ROCE % ⓘ32.9%37.9%-
Value Creation
Index ⓘ		1.41.7-

Growth Parameters ⓘ
Sales ⓘ31.649.771
Sales YoY Gr.-57%-
Adj EPS ⓘ344.2
YoY Gr.-33.3%-
BVPS (₹) ⓘ11.916.126.6
Adj Net
Profit ⓘ		2.94.16
Cash Flow from Ops. ⓘ-7.10-
Debt/CF from Ops. ⓘ-0.129.4-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANANA57%
Adj EPS ⓘNANANA33.3%
BVPSⓘNANANA34.9%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'24Mar'25TTM
Return on
Equity % ⓘ		24.929.119.7
Op. Profit
Mgn % ⓘ		12.511.3NAN
Net Profit
Mgn % ⓘ		9.28.48.5
Debt to
Equity ⓘ		00-
Working Cap
Days ⓘ		01340
Cash Conv.
Cycle ⓘ		01160

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'24Mar'25
Sales31.6249.65
Operating Expenses ⓘ + 27.6544.04
Manufacturing Costs0.030.11
Material Costs27.3743.51
Employee Cost 0.120.25
Other Costs ⓘ 0.140.17
Operating Profit ⓘ 3.965.61
Operating Profit Margin (%) 12.5%11.3%
Other Income ⓘ + 0.010
Exceptional Items ⓘ 00
Interest ⓘ 0.060.04
Depreciation ⓘ 0.020.03
Profit Before Tax ⓘ 3.895.54
Tax ⓘ 0.981.39
Profit After Tax 2.914.14
PAT Margin (%) 9.2%8.4%
Adjusted EPS (₹)3.04.0
Dividend Payout Ratio (%)0%0%

Valuation of Medistep Healthcare - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'24Mar'25

Equity and Liabilities

Shareholders Fund + 11.6916.83
Share Capital ⓘ 4.9010.47
Reserves ⓘ 6.796.37
Debt +0.120.64
Long Term Debt0.070
Short Term Debt0.050.64
Minority Interest00
Trade Payables1.412.45
Others Liabilities ⓘ 1.733.05
Total Liabilities ⓘ 14.9522.98

Fixed Assets

Net Fixed Assets ⓘ +0.150.12
Gross Block0.200.20
Accumulated Depreciation0.050.08
CWIP ⓘ 00
Investments ⓘ 00
Inventories0.931.10
Trade Receivables13.7520.11
Cash Equivalents 0.011.31
Others Assets ⓘ 0.100.33
Total Assets ⓘ 14.9522.98

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'24Mar'25
Cash Flow From Operating Activity ⓘ + -7.110.02
PBT ⓘ 3.895.54
Adjustment ⓘ 0.080.08
Changes in Working Capital ⓘ -11.08-5.58
Tax Paid ⓘ 0-0.01
Cash Flow From Investing Activity ⓘ + -0.150
Capex -0.150
Net Investments 00
Others ⓘ 00
Cash Flow From Financing Activity ⓘ + 7.241.28
Net Proceeds from Shares ⓘ 0.011
Net Proceeds from Borrowing ⓘ -0.09-0.01
Interest Paid ⓘ -0.05-0.03
Dividend Paid ⓘ 00
Others ⓘ 7.380.32
Net Cash Flow ⓘ -0.021.30

Financial Ratio

PARTICULARSMar'24Mar'25
Ratios
ROE (%)24.9229.06
ROCE (%)32.937.86
Asset Turnover Ratio2.112.62
PAT to CFO Conversion(x)-2.440
Working Capital Days
Receivable Days158.80124.50
Inventory Days10.707.40
Payable Days18.8016.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Medistep Healthcare Ltd FAQs

The current trading price of Medistep Healthcare on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Medistep Healthcare stood at ₹25.65 Cr

The latest P/E ratio of Medistep Healthcare as of 31-Dec-1969 is 4.29.

The latest P/B ratio of Medistep Healthcare as of 31-Dec-1969 is 0.68.

The 52-week high of Medistep Healthcare is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medistep Healthcare is ₹70.83 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medistep Healthcare Ltd is a below average quality company.

The key valuation ratios of Medistep Healthcare Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medistep Healthcare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Medistep Healthcare Ltd

Medistep Healthcare limited was originally incorporated on June 05, 2023 as ‘Medistep Healthcare Limited’, as a Public limited company under the Companies Act, 2013, pursuant to a certificate of incorporation issued by Registrar of Companies, Gujarat. Thereafter the company acquired the business of Proprietorship Concern of one of its Promoter Ms. Prajapati hetalben girdharilal viz, M/s MG Pharma through the business transfer agreement dated July 02, 2023. Subsequently the business of the sole proprietorship firm was transferred into Medistep healthcare Limited.

Medistep Healthcare operates in the pharmaceutical industry and is involved in the business of trading of pharmaceutical products, intimate care and hygiene products, surgical products & nutraceutical products and manufacturing of intimate and nutraceutical products. The company has strategically expanded its operations by acquiring the business of M/s MG Pharma, a proprietorship concern owned by one of its promoters, Ms. Prajapati Hetalben Girdharilal. This acquisition was executed through a business transfer agreement dated July 02, 2023. 

Medistep Healthcare is a Pharmaceutical Company that has carved a niche in the Healthcare Industry through its experience in manufacturing Sanitary pads, Energy powder and trading a diverse range of pharmaceutical products, Nutraceutical products, Intimate Products and surgical products through distribution network.

The company is led by a professional and experienced management team. Its Promoters Girdhari Lal Prajapat, Dabhi Vipul Gobarbhai and Prajapati Hetalben Girdharilal, all have extensive experience in the Indian pharmaceutical industry. Its Promoters have been the pillars of the company’s growth and have built a strong value system for the company. With their enriching experience and progressive thinking, it is planning to grow in the pharmaceutical Industry.

Business area of the company

The company primarily engaged in the business of manufacturing and distribution, wholesale and retail trade of all kinds of pharmaceuticals including controlled drugs, API, antibiotics, drugs, medicine, biologicals, nutraceuticals, organic, food items, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines etc.

Products of the company

  • Drystep sanitary pad
  • Vitastep Z powder

History and milestones

  • 2023: The company was incorporated as Public Limited Company under the name ‘Medistep Healthcare Limited’
  • 2023: M/s MG Pharma was incorporated on July 05, 2018 or carrying on business of trading/distribution of pharmaceutical products, intimate care and hygiene products, surgical products and equipment and Nutraceutical products. On July 02, 2023, Medistep healthcare Limited has acquired the entire running business on a going concern basis with Asset and Liabilities of M/s MG Pharma, a Sole Proprietorship owned by its Promoter, Ms. Prajapati hetalben girdharilali.
  • 2023: Obtained FSSAI license for manufacturing of sanitary pad and energy powder.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: